Paolini John F.

US insider· US
Sign in for alerts
  • REDUCEDStale

    Kiniksa Pharmaceuticals Intl · NASDAQ

    −4,029 sh · $319.4K

    Filed 3 Sept 2026SEC Form 4view source
  • ACQUIREDStale

    Kiniksa Pharmaceuticals Intl · NASDAQ

    +2,497 sh

    Filed 3 Sept 2026SEC Form 4view source
  • ACQUIREDStale

    Kiniksa Pharmaceuticals Intl · NASDAQ

    +1,750 sh

    Filed 3 Sept 2026SEC Form 4view source
  • ACQUIREDStale

    Kiniksa Pharmaceuticals Intl · NASDAQ

    +1,624 sh

    Filed 3 Sept 2026SEC Form 4view source
  • ACQUIREDStale

    Kiniksa Pharmaceuticals Intl · NASDAQ

    +2,457 sh

    Filed 3 Sept 2026SEC Form 4view source